Cargando…

Management of muscle invasive, locally advanced and metastatic urothelial carcinoma of the bladder: a literature review with emphasis on the role of surgery

Locally advanced (T3b, T4 and N1−N3) and metastatic urothelial bladder cancer (BCa) is a lethal disease with poor survival outcomes. Combination chemotherapy remains the treatment of choice in patients with metastatic disease and an important part of treatment in addition to radical cystectomy (RC)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abufaraj, Mohammad, Gust, Kilian, Moschini, Marco, Foerster, Beat, Soria, Francesco, Mathieu, Romain, Shariat, Shahrokh F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5071186/ https://www.ncbi.nlm.nih.gov/pubmed/27785430 http://dx.doi.org/10.21037/tau.2016.08.23

Ejemplares similares

Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study
por: Abufaraj, Mohammad, et al.
Publicado: (2016)

Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis
por: Mori, Keiichiro, et al.
Publicado: (2022)

Genetic determinants for chemo- and radiotherapy resistance in bladder cancer
por: Mari, Andrea, et al.
Publicado: (2017)

Diagnostic accuracy, clinical utility and influence on decision‐making of a methylation urine biomarker test in the surveillance of non‐muscle‐invasive bladder cancer
por: D'Andrea, David, et al.
Publicado: (2019)

An up-to-date catalog of available urinary biomarkers for the surveillance of non-muscle invasive bladder cancer
por: Soria, Francesco, et al.
Publicado: (2018)

PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients: Dramatic improvement of prognosis and overall survival after decades of hopelessness in patients with metastatic urothelial cancer
por: Resch, Irene, et al.
Publicado: (2018)

Predictive models and prognostic factors for upper tract urothelial carcinoma: a comprehensive review of the literature
por: Mbeutcha, Aurélie, et al.
Publicado: (2016)

Biomarkers for the prediction of oncologic outcomes in non-muscle invasive bladder cancer: state of affairs and new frontiers
por: Soria, Francesco, et al.
Publicado: (2018)

How to optimally manage elderly bladder cancer patients?
por: Soria, Francesco, et al.
Publicado: (2016)

Detection of Urothelial Bladder Cancer Based on Urine and Tissue Telomerase Activity Measured by Novel RT-TRAP-2PCR Method
por: Glukhov, Alexander, et al.
Publicado: (2021)

Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer
por: Soria, Francesco, et al.
Publicado: (2018)

Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancer
por: Katayama, Satoshi, et al.
Publicado: (2021)

A systematic review and meta‐analysis of the impact of lymphovascular invasion in bladder cancer transurethral resection specimens
por: Mari, Andrea, et al.
Publicado: (2018)

Association of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalization
por: D’Andrea, David, et al.
Publicado: (2019)

Update on systemic treatment of upper tract urothelial carcinoma: a narrative review of the literature
por: Gust, Kilian M., et al.
Publicado: (2021)

Building bridges in urothelial carcinoma to face common challenges
por: Mathieu, Romain, et al.
Publicado: (2016)

Contemporary concepts and controversies in the diagnosis and management of urothelial carcinoma
por: Shariat, Shahrokh F., et al.
Publicado: (2016)

Further Understanding of Urokinase Plasminogen Activator Overexpression in Urothelial Bladder Cancer Progression, Clinical Outcomes and Potential Therapeutic Targets
por: Grossmann, Nico C, et al.
Publicado: (2021)

Functional Outcomes after Local Salvage Therapies for Radiation-Recurrent Prostate Cancer Patients: A Systematic Review
por: Abufaraj, Mohammad, et al.
Publicado: (2021)

Differential Prognosis and Response of Denovo vs. Secondary Muscle-Invasive Bladder Cancer: An Updated Systematic Review and Meta-Analysis
por: Pones, Mario, et al.
Publicado: (2021)

Molecular markers in bladder cancer
por: Soria, Francesco, et al.
Publicado: (2018)

Prognostic value of hepatocyte growth factor for muscle-invasive bladder cancer
por: Katayama, Satoshi, et al.
Publicado: (2022)

Impact of the Level of Urothelial Carcinoma Involvement of the Prostate on Survival after Radical Cystectomy
por: Moschini, Marco, et al.
Publicado: (2017)

Sex-related differences in non-urothelial variant histology, non-muscle invasive bladder cancer
por: Flammia, Rocco Simone, et al.
Publicado: (2022)

Prognostic value of albumin to globulin ratio in non-muscle-invasive bladder cancer
por: Quhal, Fahad, et al.
Publicado: (2021)

SEOM Clinical Guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2016)
por: Lázaro, M., et al.
Publicado: (2016)

SEOM clinical guideline for treatment of muscle-invasive and metastatic urothelial bladder cancer (2018)
por: González del Alba, A., et al.
Publicado: (2018)

Prognostic value of T1 substaging on oncological outcomes in patients with non-muscle-invasive bladder urothelial carcinoma: a systematic literature review and meta-analysis
por: Kardoust Parizi, Mehdi, et al.
Publicado: (2019)

Pre-therapy serum albumin-to-globulin ratio in patients treated with neoadjuvant chemotherapy and radical nephroureterectomy for upper tract urothelial carcinoma
por: Pradere, Benjamin, et al.
Publicado: (2020)

Performance of fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography imaging for lymph node staging in bladder and upper tract urothelial carcinoma: a systematic review
por: Aydh, Abdulmajeed, et al.
Publicado: (2020)

Preoperative plasma level of endoglin as a predictor for disease outcomes after radical cystectomy for nonmetastatic urothelial carcinoma of the bladder
por: Laukhtina, Ekaterina, et al.
Publicado: (2021)

Prognostic Role of Preoperative Vascular Cell Adhesion Molecule-1 Plasma Levels in Urothelial Carcinoma of the Bladder Treated With Radical Cystectomy
por: Mori, Keiichiro, et al.
Publicado: (2022)

The impact of moderate wine consumption on the risk of developing prostate cancer
por: Vartolomei, Mihai Dorin, et al.
Publicado: (2018)

Comparison of perioperative complications and health‐related quality of life between robot‐assisted and open radical cystectomy: A systematic review and meta‐analysis
por: Kimura, Shoji, et al.
Publicado: (2019)

Association of De Ritis ratio with oncological outcomes in patients with non-muscle invasive bladder cancer (NMIBC)
por: Laukhtina, Ekaterina, et al.
Publicado: (2020)

Comparative Outcomes of Primary Versus Recurrent High-risk Non–muscle-invasive and Primary Versus Secondary Muscle-invasive Bladder Cancer After Radical Cystectomy: Results from a Retrospective Multicenter Study
por: Grossmann, Nico C., et al.
Publicado: (2022)

Urethrectomy at the time of radical cystectomy for non-metastatic urothelial carcinoma of the bladder: a collaborative multicenter study
por: Laukhtina, Ekaterina, et al.
Publicado: (2022)

The present and future of non-muscle invasive bladder cancer
por: Moschini, Marco, et al.
Publicado: (2019)

Incidence and outcome of salvage cystectomy after bladder sparing therapy for muscle invasive bladder cancer: a systematic review and meta-analysis
por: Schuettfort, Victor M., et al.
Publicado: (2020)

The Impact of Primary Versus Secondary Muscle-invasive Bladder Cancer at Diagnosis on the Response to Neoadjuvant Chemotherapy
por: D'Andrea, David, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jk9cgaa7id24rm84h60hvadi55